The Impact of COVID-19 on Nuclear Medicine in Europe
Open Access
- 1 January 2022
- journal article
- review article
- Published by Elsevier BV in Seminars in Nuclear Medicine
- Vol. 52 (1), 17-24
- https://doi.org/10.1053/j.semnuclmed.2021.06.022
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- 18F-Fluorodeoxyglucose Uptake in Patient With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Referred to Positron Emission Tomography/Computed Tomography for NSCLC RestagingJournal of Thoracic Oncology, 2020
- No time like the present: time to re-think our habits in science and continuous medical education?European Journal of Nuclear Medicine and Molecular Imaging, 2020
- COVID-19: guidance for infection prevention and control in nuclear medicineNuclear Medicine Communications, 2020
- COVID-19 pandemic: guidance for nuclear medicine departmentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19Nuklearmedizin, 2020
- Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and ExperiencesJournal of Nuclear Medicine, 2020
- Dementia care during COVID-19The Lancet, 2020
- The potential added value of FDG PET/CT for COVID-19 pneumoniaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- A novel coronavirus outbreak of global health concernThe Lancet, 2020